A Randomized Comparative Clinical Study on Efficacy of Visaghna (anti poison) Mahakasaya-Ghanavati(poly herbal drug) and Haridrakhanda(herbo-mineral drug) in Sitapitta with the special reference of urticaria
Phase 2
- Conditions
- Health Condition 1: L509- Urticaria, unspecified
- Registration Number
- CTRI/2024/05/066733
- Lead Sponsor
- ational institute of ayurveda jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients between the age group 18-60 years of age
Patients of either gender
The patients having classical signs and symptoms of Sitapitta
Patients willing to participate in the clinical trial
Exclusion Criteria
Patient with long term history of steroid and cytotoxic treatment
Pregnant and lactating women
Patients having concomitant illness like uncontrolled Hypertension uncontrolled Diabetes mellitus HIV Malignancy etc
Anaphylaxis Angioedema of the lips tongue or larynx etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Outcome <br/ ><br>Change in classical symptoms of sheetpitta such as <br/ ><br>Wheals or hives <br/ ><br>Itching <br/ ><br>Prickling sensation <br/ ><br>Nausea or vomitting <br/ ><br>Fever <br/ ><br>Burning sensation <br/ ><br> <br/ ><br>Timepoint: 30days
- Secondary Outcome Measures
Name Time Method Change in IgE DLC ESRTimepoint: 30 days